
Effects of MYBPC3 loss-of-function mutations preceding …
Mutations in cardiac myosin binding protein C (MyBP-C, encoded by MYBPC3) are the most common cause of hypertrophic cardiomyopathy (HCM). Most MYBPC3 mutations result in premature termination codons (PTCs) that cause RNA degradation and a reduction ...
An Update on MYBPC3 Gene Mutation in Hypertrophic …
Hypertrophic cardiomyopathy (HCM) is the most prevalent genetically inherited cardiomyopathy that follows an autosomal dominant inheritance pattern. The majority of HCM cases can be attributed to mutation of the MYBPC3 gene, which encodes cMyBP-C, a crucial structural protein of the cardiac muscle.
Titin-truncating mutations associated with dilated cardiomyopathy …
2020年11月2日 · Phosphorylation levels of troponin I (TnI) and myosin binding protein-C (MyBP-C) were manipulated using protein kinase A and λ phosphatase. mRNA sequencing was employed to overview gene expression profiles. We found that Ca 2+ sensitivity of myofibrils carrying TTN mutations was significantly higher than in myofibrils from donor hearts.
A Review of the Giant Protein Titin in Clinical Molecular …
Titin (TTN) is known as the largest sarcomeric protein that resides within the heart muscle. Due to alternative splicing of TTN, the heart expresses two major isoforms (N2B and N2BA) that incorporate four distinct regions termed the Z-line, I-band, A-band, and M-line.
Titin-truncating mutations associated with dilated ... - PubMed
2022年1月7日 · Titin-truncating mutations lead to decreased length-dependent activation and increased elasticity of myofibrils. Phosphorylation levels of TnI and MyBP-C seen in the left ventricles are essential for the length-dependent changes in Ca2+ sensitivity in healthy donors, but they are reduced in DCM pati …
Spatial and Functional Distribution of MYBPC3 Pathogenic …
2020年8月25日 · Pathogenic variants in MYBPC3, encoding cardiac MyBP-C (myosin binding protein C), are the most common cause of familial hypertrophic cardiomyopathy. A large number of unique MYBPC3 variants and relatively small genotyped hypertrophic cardiomyopathy cohorts have precluded detailed genotype-phenotype correlations.
Cardiac myosin binding protein C gene is specifically expressed in ...
Cardiac myosin binding protein C (MyBP-C) is a substantial component of the sarcomere, with both structural and regulatory roles. The gene encoding cardiac MyBP-C in humans is located on chromosome 11p11.2, and mutations that are most predicted to produce truncated proteins have been identified in t …
TTN and MYBPC3 encode the myofilament proteins titin and myosin-binding protein C, respectively. We have now identified a novel myofilament com-ponent, MyBP-HL, and described mice with disrup-tion in the Mybphl gene as having cardiomyopathy and arrhythmias.
MYBPC3 Gene - GeneCards | MYPC3 Protein | MYPC3 Antibody
2024年12月25日 · MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction.
Novel MYBPC3 Mutations & assoc. with Indian Cardiomyopathies
2023年3月17日 · Cardiac Myosin Binding Protein C (MyBP-C_OMIM-600958), one of the thick filaments exhibited across the C zone of A-bands of sarcomeres, binds ß-myosin (ß-MYH7_OMIM-160710) in thick filaments and titin (TTN_OMIM-188840) in elastic filaments. 1,2 It serves as a control that limits cross-bridge interactions between myosin and actin. 3,4 ...